Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol standard dosing pathway in hospitalized Chinese patients with acute coronary syndrome
ChiCTR1800014288Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metoprolol in acute coronary syndrome (ACS), sponsored by Chinese PLA General Hospital. Primary endpoint: Percentage of patients achieving target dose at discharge. Started Dec 2017; status: recruiting.
02
Drugs
metoprolol
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR1800014288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014288.